Legislators
Bills
Statements
Represent

H.R.1919: Safeguarding America's Pharmaceuticals Act of 2013

About this Bill

This bill was introduced in the 113th Congress
This bill is primarily about health
You can read the bill
Sponsor Robert E. Latta, R-Ohio
Total Cosponsors 20 (5 Democrats, 15 Republicans)
Introduced May 9, 2013
Latest Major Action June 4, 2013
See it on GovTrack
See it on C-SPAN

Bill Progress

  • Bill introduced in the House   
  • Bill passed in the House   
  • Bill passed in the Senate   
  • Bill signed into law

Bill Summary

Safeguarding America's Pharmaceuticals Act of 2013 - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to establish requirements to facilitate the tracing of drug products through the pharmaceutical supply distribution chain.

Requires the Secretary of Health and Human Services (HHS) to establish standards for the exchange of transaction information.

Requires the Secretary to establish processes to: (1) provide waivers of requirements for undue economic hardship or emergency medical reasons; (2) provide waivers of requirements relating to product identifiers for prescription drug products packaged without sufficient space to bear the information; and (3) determine other prescription drug products or transactions that should be exempt from the requirements of this Act.

Establishes requirements for drug manufacturers, wholesalers, dispensers, and repackagers to ensure that all prior transaction information is provided at each transfer of ownership. Requir...

(Source: Congressional Research Service)

Bill Actions

Date Description
June 4, 2013 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
June 3, 2013 Motion to reconsider laid on the table Agreed to without objection.
June 3, 2013 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2969-2978)
June 3, 2013 DEBATE - The House proceeded with forty minutes of debate on H.R. 1919.
June 3, 2013 Considered under suspension of the rules. (consideration: CR H2968-2984)
June 3, 2013 Mr. Latta moved to suspend the rules and pass the bill, as amended.
June 3, 2013 Placed on the Union Calendar, Calendar No. 65.
June 3, 2013 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-93.
May 10, 2013 Referred to the Subcommittee on Health.
May 9, 2013 Referred to the House Committee on Energy and Commerce.